169 patents
Page 2 of 9
Utility
Systems, devices and methods for microfluidic analysis
23 May 23
Described herein are various inventions and embodiments thereof, directed to systems, devices, and methods for analysis of a biofluid, as well as controlling a biofluid analysis system using a microfluidic device.
Robert Justice Shartle, Sherb M. Edmondson, Jr., Bob Larson
Filed: 3 Oct 19
Utility
Heterocyclic Compounds and Their Use for Treatment of Helminthic Infections and Diseases
11 May 23
Natalie Hawryluk, Stacie S. Canan, Kevin R. Condroski, Graham Kyne, Matthew Bedore, Sanjay Menon
Filed: 4 Oct 22
Utility
Immunomodulating O-het/aryl Azalides
4 May 23
Richard Andrew Ewin, Mark R. Cox, Imelda Hot, Matthew W. Bedore, Tomasz Respondek, Susan M.K. Sheehan
Filed: 11 Mar 21
Utility
Immunomodulating Trifluoromethyl-aminal Azalides
4 May 23
Todd M. Maddux, Tomasz Respondek
Filed: 11 Mar 21
Utility
Immunomodulating Azalides
27 Apr 23
Mark R. Cox, Richard Andrew Ewin, Tomasz Respondek, Imelda Hot, Todd M. Maddux
Filed: 6 Sep 22
Utility
Immunomodulating Imine-oxazoline Azalides
27 Apr 23
Christopher A. Zook, Todd M. Maddux, Tomasz Respondek
Filed: 11 Mar 21
Utility
Microfluidic rotor device
18 Apr 23
Described herein are various embodiments directed to rotor devices, systems, and kits.
Robert Justice Shartle, Gregory Trigub
Filed: 22 Aug 19
Utility
Methods and Composition for Induction of Immune Response
30 Mar 23
The invention provides a substantially antigen-free composition for induction of innate immune response in a bird or a mammal, the composition comprising a saponin, a sterol, a quaternary amine, and a polyacrylic polymer to the mammal or bird.
Paul Joseph Dominowski, Duncan Mwangi, Joseph M. Bricker, Dennis L. Foss, Sharath K. Rai, Suman Mahan
Filed: 28 Apr 22
Utility
Swine vaccination system
28 Mar 23
A system for vaccinating swine according to one embodiment includes a housing having an open first end and an open opposite second end.
Mahesh Kumar
Filed: 29 Sep 16
Utility
Signal amplification in solution-based plasmonic specific-binding partner assays
28 Mar 23
The present invention relates to analyte detection devices and methods of using such devices to detect minute quantities of a target analyte in a sample.
Rajesh K. Mehra, Vincent Chiang, Kenneth Aron, Jessica Frisz
Filed: 29 Nov 21
Utility
Antimicrobial Peptides and Methods of Using Same
16 Mar 23
Antimicrobial peptides of general formula X0X1X2CX3X4X5CX6X7X8X9CYX10X11CX12X13 are provided.
Michael Kuhn, Christopher A. Zook, Derek James Sheehan, Eric Baima, Richard Andrew Ewin, Hilary Phelps
Filed: 6 May 22
Utility
Methods Of Vaccine Administration
16 Mar 23
This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral antigens, a bacterin, or both, and wherein the vaccine is administered subcutaneously or orally according to the schedules provided herein.
Cassius McAllister Tucker, John David Haworth
Filed: 14 Nov 22
Utility
Serotonin 5-HT2B Inhibitory Compounds
9 Mar 23
Richard A. Ewin, Ashley E. Fenwick, Govindan Subramanian
Filed: 22 Jul 22
Utility
Teat seal formulation
7 Feb 23
A seal formulation for forming a physical barrier in the teat canal of a non-human animal for prophylactically controlling infection of a mammary gland by a mastitis-causing organism comprises a polymer in a gel base wherein the polymer is a lower alkyl vinyl ether-maleic anhydride copolymer or a salt derivative thereof.
Francisco Javier Molins Albanell, Brendan Gerard Smith, James Kennedy, Fiona NĂ ChearĂșil
Filed: 19 Oct 16
Utility
Peptides and methods for the detection of Lyme disease antibodies
7 Feb 23
The invention provides compositions (e.g., peptide compositions) useful for the detection of antibodies that bind to Borrelia antigens.
Rajesh K. Mehra, Kenneth P. Aron, Dennis M. Bleile, Jeremy Walker, Cristina Cuesico
Filed: 14 Jan 21
Utility
Recombinant Herpesvirus of Turkey Vectors Expressing Antigens of Avian Pathogens and Uses Thereof
29 Dec 22
The invention relates to recombinant viral vectors for the insertion and expression of foreign genes for use in safe immunizations to protect against a variety of pathogens.
Sing RONG, Yugang LUO, Tyler BROWN
Filed: 31 Aug 22
Utility
Interleukin-31 monoclonal antibodies for veterinary use
20 Dec 22
A monoclonal antibody, or antigen-binding portion thereof is provided that specifically binds to a region on a mammalian IL-31 protein involved with interaction of the IL-31 protein with its co-receptor, wherein the binding of said antibody to said region is impacted by mutations in a 15H05 epitope binding region selected from: a region between about amino acid residues 124 and 135 of a feline IL-31 sequence represented by SEQ ID NO: 157 (Feline_IL31_wildtype); a region between about amino acid residues 124 and 135 of a canine IL-31 sequence represented by SEQ ID NO: 155 (Canine_IL31); and a region between about amino acid residues 118 and 129 of an equine IL-31 sequence represented by SEQ ID NO: 165 (Equine_IL31).
Gary Francis Bammert, Steven Alan Dunham, Sebastian C. J. Steiniger
Filed: 24 Jan 19
Utility
Device for artificially inseminating a mammal
20 Dec 22
A device for artificially inseminating a mammal with sperm from a male breeding animal is disclosed, the sperm being introduced through the vagina of the animal into or onto the uterus of the animal which is to be inseminated.
Wolfgang Auer
Filed: 15 Apr 19
Utility
Methods of vaccine administration
13 Dec 22
This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral antigens, a bacterin, or both, and wherein the vaccine is administered subcutaneously or orally according to the schedules provided herein.
Cassius McAllister Tucker, John David Haworth
Filed: 20 May 14
Utility
Methods of vaccine administration
13 Dec 22
This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral antigens, a bacterin, or both, and wherein the vaccine is administered subcutaneously or orally according to the schedules provided herein.
Cassius McAllister Tucker, John David Haworth
Filed: 24 Jun 20